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Protocol
AbstrACt
Introduction Dietary zinc (Zn) deficiency is a global 
problem, particularly in low-income and middle-income 
countries where access to rich, animal-source foods of 
Zn is limited due to poverty. In Pakistan, Zn deficiency 
affects over 40% of the adult female population, resulting 
in suboptimal immune status and increased likelihood of 
complications during pregnancy.
Methods and analysis We are conducting a double-blind, 
randomised controlled feeding study with cross-over 
design in a low-resource setting in Pakistan. Households 
were provided with flour milled from genetically and 
agronomically biofortified grain (Zincol-2016/NR-421) 
or control grain (Galaxy-2013). Fifty households were 
recruited. Each household included a woman aged 16–49 
years who is neither pregnant nor breastfeeding, and 
not currently consuming nutritional supplements. These 
women were the primary study participants. All households 
were provided with control flour for an initial 2-week 
baseline period, followed by an 8-week intervention period 
where 25 households receive biofortified flour (group A) 
and 25 households receive control flour (group B). After 
this 8-week period, groups A and B crossed over, receiving 
control and biofortified flour respectively for 8 weeks. 
Tissue (blood, hair and nails) have been collected from the 
women at five time points: baseline, middle and end of 
period 1, and middle and end of period 2.
Ethics and dissemination Ethical approval was granted 
from the lead university (reference no. STEMH 697 FR) and 
the collaborating institution in Pakistan. The final study 
methods (including any modifications) will be published in 
peer-reviewed journals, alongside the study outcomes on 
completion of the data analysis. In addition, findings will be 
disseminated to the scientific community via conference 
presentations and abstracts and communicated to 
the study participants through the village elders at an 
appropriate community forum.
registration details The trial has been registered with 
the ISRCTN registry, study ID ISRCTN83678069.
IntroduCtIon
Dietary zinc (Zn) deficiency is a global 
problem, affecting 17% of the world’s popu-
lation, with the greatest burden in low-in-
come and middle-income countries.1 2 The 
most recent national survey in Pakistan indi-
cates that over 40% of women are Zn defi-
cient.3 The consequences of Zn deficiency 
are profound and far-reaching, ranging from 
increased individual morbidity and mortality 
to problems with community and regional 
economic development.4 
Attempts to alleviate the problem of Zn 
deficiency, both in Pakistan and in other 
strengths and limitations of the study
 ► The study is the first randomised controlled trial to 
determine the effectiveness of consuming flour from 
the Zincol-2016/NR-421 strain of wheat on Zn sta-
tus in women of childbearing age.
 ► The study will evaluate the use of novel biomarkers 
of Zn status in low-resource settings.
 ► A limitation of this study is the relatively small sam-
ple size (n=50). This is compensated for by the 
cross-over design, which strengthens the statistical 
power.
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countries, have followed several strategies. Providing 
micronutrient supplements, usually using ‘sprinkles’, has 
been attempted under different circumstances, gener-
ally with some success.5 However, it is an expensive and 
intensive approach, and without close supervision it can 
often be that the intended target, for example a preg-
nant woman, does not end up receiving the supplement. 
Fortification of foods at the processing stage has also 
been widely adopted, but there are significant problems 
with compliance and efficacy, both at the fortification 
stage where quality control is ineffective and at the level 
of consumer uptake. A major issue is that poorer house-
holds in rural areas of developing countries typically 
grow the majority of their food and process it at village or 
community level. Thus, cereal fortification at large-scale 
processing facilities may not reach poorer households, 
where micronutrient deficiencies are often more preva-
lent and severe.
An alternative approach is to intervene at agricultural 
production stage through biofortification to achieve 
greater concentrations of bioavailable vitamins or 
elements in the edible portion of crops.6 Biofortification 
can be realised through crop breeding or application of 
element-enriched fertilisers, known as ‘agronomic biofor-
tification’, which is particularly important in Pakistan 
where plant-available soil Zn concentrations are low.7 
Such Zn-deficient soils that constitute 52% at national 
scale are also prevalent in Peshawar, Khyber Pakh-
tunkhwa Province, where plant-available soil Zn concen-
trations are significantly below the threshold 1 mg/kg in 
75% of the soils analysed. Farmers in Pakistan rarely apply 
Zn fertilisers to their crops except for rice. Biofortifica-
tion approaches have focused on staple crops because 
they are widely consumed including households with 
low purchasing power. Recently, varieties of maize, pearl 
millet and beans with high iron (Fe) and Zn concentra-
tions have been developed by the HarvestPlus programme 
for deployment in low-income settings. Human feeding 
studies have demonstrated that such varieties can lead to 
improvements in Fe and Zn intake and status,8 9 although 
there may be issues with low bioavailability.10 Agronomic 
biofortification has not previously been deployed in a 
low-income setting but does have policy precedent in 
Finland, where granular fertilisers were enriched with 
selenium (Se) since the mid-1980s with consequent 
increases in human dietary Se intakes and eventual elimi-
nation of Se deficiency as a public health problem.11
Preliminary studies have shown that Zn concentrations 
in wheat can be raised substantially through biofortifica-
tion strategies.12 It is notable that increasing levels of nutri-
ents in the whole plant is not sufficient; elements must be 
translocated to the edible component of the grain (endo-
sperm) and must be bioavailable. Phytic acid (PA) is the 
most important inhibitor of Zn absorption from wheat; 
therefore, the Zn:PA molar ratio of the endosperm is an 
important consideration. The process of element accu-
mulation in the endosperm is not simple. For example, 
Zn moves through many different transport processes 
prior to being deposited in the seed.13 In a recent set of 
experiments within the HarvestPlus programme over a 
period of 8 years, scientists in Pakistan using traditional 
breeding techniques have been able to generate a ‘high 
Zn’ variety of wheat that is adapted to Pakistan condi-
tions. The variety (Zincol-2016/NR-421) contains more 
Zn per kilogram of grain compared with traditional vari-
eties. However, grain Zn concentration will also depend 
on the availability of Zn in the soil, and there are likely to 
be synergistic effects of breeding for high Zn with appli-
cation of Zn fertilisers.
The efficacy of increasing dietary intake through 
biofortification on individual and population Zn status 
is notoriously difficult to measure. The assessment of Zn 
status has been the subject of considerable research and 
is summarised comprehensively in two recent reviews 
supported by multinational expert groups.14 15 Both 
reviews conclude that plasma or serum Zn concentration, 
the most widely used biomarker, is useful provided that 
various confounding factors are considered (including 
concurrent infection and inflammation). However, the 
plasma/serum must be collected following stringent 
methodology to avoid contamination and can be difficult 
to achieve in field settings. Hair Zn concentration is also 
potentially useful, and samples are easy to collect and 
store. In addition, emerging techniques, including the 
measurement of DNA fragmentation using the Comet 
assay and analysis of nail Zn concentration using laser 
ablation, are gaining credibility as useful biomarkers of 
Zn status. However, field trials are needed to evaluate 
their usefulness.
The primary aim of this study is to measure the impact 
of consuming flour made from the recently released 
high-Zn wheat grain variety Zincol-2016/NR-421 on 
dietary Zn intake and biomarkers of Zn status in a 
low-resource rural community setting in Pakistan. The 
secondary aim is to evaluate the potential usefulness of 
new biomarkers of Zn status. These aims will be achieved 
through conducting a randomised controlled feeding 
study with a cross-over design. Comparison of outcome 
measures will be made following consumption of flour 
made from the biofortified wheat variety, Zincol-2016/
NR-421, and the control, non-biofortified variety, Galaxy. 
The trial has been registered with the ISRCTN registry, 
study ID ISRCTN83678069.16
MEthods And AnAlysIs
study setting and recruitment
This study was conducted from the Health Centre that 
serves a community of approximately 5000 house-
holds in an area of 8 km2 on the outskirts of Peshawar 
in Khyber Pakhtunkhwa (KPK). This community was 
chosen because previous studies have indicated that Zn 
deficiency is widespread, the diet is limited and primarily 
vegetable-based (thus low in bioavailable Zn) and the 
staple is wheat which is used for making chapati and 
roti.17 The catchment area, known as a Union Council, 
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is made up of 10 villages (clusters). Out of 10 clusters in 
the union council, 5 were randomly selected, from which 
equal numbers of households were randomly selected 
for the study. Selection of these clusters and house-
holds into intervention or control arm was done using a 
block design. Water samples were collected in duplicate 
from four different communal tube wells (hand pump) 
supplying each village and analysed for mineral content 
by inductively coupled plasma-mass spectrometry (ICP-
MS). The mean Zn concentration of the water from one 
cluster was high enough to significantly impact on daily Zn 
intake (>250 µg/L); therefore, this cluster was eliminated 
from the study and an alternative cluster was randomly 
selected. The mean Zn concentration in the water anal-
ysed from the five included clusters was ≤120 µg/L and 
therefore not considered to add significantly to the daily 
Zn intake, based on a consumption of 2–4 L water per day 
(<0.5 mg Zn per day).
Ten households from each cluster were randomly 
selected. The head of the household was approached, 
the purpose of the study explained and, if eligible, 
the family invited to participate in the trial. If the 
head of the household declined, another house from 
the cluster was randomly selected and the invitation 
process repeated. Inclusion criteria were the house-
hold included a woman aged 16–49 years who was 
neither pregnant nor breastfeeding, and not currently 
consuming nutritional supplements. When there was 
more than one eligible woman in the household, one 
was conveniently selected with agreement from the head 
of the household. There were no additional exclusion 
criteria. Following informed consent, each household 
was assigned to treatment arm A or B (refer to figure 1) 
using a block design. A sample size of 40, 95% signifi-
cance level (two-sided) and 90% power, will enable an 
increase in plasma Zn concentration of 3.1 µg/dL to be 
detected. The target was to recruit 50 households (50 
eligible women) to be able to accommodate a 20% attri-
tion rate during the 18-week study. The project manager 
led the recruitment process because he is known to the 
community through previous health-related projects 
associated with the Abaseen Foundation PK (AFPK), a 
local non-governmental organisation and key member 
of this project team, along with its sister organisation 
Abaseen Foundation UK. There is a high level of trust 
and cooperation between community members and the 
AFPK who operate the health centre that serves this 
Union Council; therefore, high levels of participant 
enrolment has been achieved. The project manager was 
responsible for allocating participants to each arm of the 
cross-over trial using a block design. Only the project 
manager had access to this information.
The participants and the remaining research team 
members, including the PI and Co-Is, database manager 
and data analysts were blind to the order in which 
households received the biofortified or control flour. 
Unblinding was permissible if any adverse reactions are 
reported by the households during the trial.
study design
We have conducted a randomised controlled feeding 
study with cross-over design in which households were 
provided with flour milled from genetically and agro-
nomically biofortified grain (Zincol-2016/NR-421) or 
control grain (Galaxy-2013). Galaxy-2013 was chosen for 
the control grain because it is widely cultivated across the 
country and is popular among farmers due to its higher 
yield. It did not receive Zn-containing fertilisers. Zincol-
2016 (formerly known as NR-421 strain/line) was bred 
by the National Agriculture Research System, Pakistan 
with the support of HarvestPlus and approved by the 
Punjab Seed Council, Pakistan in 2016.18 The grain for 
both the genotypes was sown at a farm in District Vehari , 
Punjab, Pakistan in November 2016 and harvested in May 
2017 by our project partner, Fauji Fertilizer Company 
(FFC) Limited. During the growing period, Zn-enriched 
fertiliser (Zn 13% as EDTA Zn) was applied to Zincol-
2016 genotype at 1.25 kg/ha through injection into the 
irrigation system. This was followed by five foliar sprays of 
Zn (ZnSO4·H2O 33% Zn) applied at 1 kg/ha of product 
dissolved in 250 L of water and sprayed per hectare at the 
booting stage. Analyses revealed that the pre-harvest Zn 
concentration in grains were 62 (SD 7.7) mg/kg and 27 
(SD 4.3) mg/kg for the biofortified and control grain, 
respectively. The grain was transported from the farm to 
the study field site in clearly labelled sacks (control and 
biofortified). The bags of grain were manually cleaned 
Figure 1 Schematic overview of objective 1, randomised 
controlled feeding study with cross-over design.
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(hand removal of debris, stones, stalks), mixed and milled 
at a local facility. Care was taken to avoid cross-contamina-
tion from previously milled grain. Samples of grain from 
each sack (top, middle and bottom) were retained for 
analysis.
The intervention trial was composed of a 2-week 
baseline equilibration period and two 8-week interven-
tion/control periods. The baseline period started on 1 
October 2017. During the baseline period, all the partici-
pating households were provided with control flour. After 
2 weeks, group A received biofortified flour and group 
B received control flour. After 8 weeks, the two groups 
will cross over, with group A receiving control flour and 
group B receiving biofortified flour for the final 8 weeks 
(figure 1). Freshly milled flour was provided on a fort-
nightly basis for consumption by the entire household 
(average seven individuals, including children). Families 
will be asked not to consume any other flour within the 
household during the 18-week study period. Compli-
ance was monitored at each flour distribution time point 
through interview with the head of the household. The 
number of meals consumed outside the household by the 
primary study participant (woman of childbearing age) 
was recorded. Our previous knowledge of this commu-
nity indicates that, other than community events such 
as weddings, it is unusual for women to eat outside the 
home.
Primary outcome measures
Flour is used primarily for making roti and chapati in 
this community. The contribution of the total Zn intake 
from foods made from flour will be determined using 
24-hour recall, coupled with food composition databases 
(eg, WinDiets 2005 Research software, Robert Gordon 
University, UK). In addition, a selection of composite 
meal samples will be analysed. The impact of consuming 
the biofortified flour on the Zn status of women of child-
bearing age will be assessed by measuring plasma Zn 
concentration on ICP-MS analysis, DNA fragmentation 
by Comet assay, and hair and nail Zn concentration by 
ICP-MS. In addition, we will measure concentrations 
of inflammatory biomarkers C-reactive protein (CRP) 
and alpha 1-acid glycoprotein that will be used to adjust 
plasma Zn concentration if required.19
Dietary analysis
Dietary nutrient intake will be assessed by analysing 
the 24-hour recalls that were collected by interviewing 
the women participants by the study nutritionist, who 
has local knowledge of the foods consumed and speaks 
Pushto, the local language. From our previous research,17 
we know that the local diet is very limited in variety and 
monotonous and therefore a total of five recall interviews, 
taken at each of the sampling points (figure 1), will give a 
good estimate of typical nutrient intake. Portion sizes will 
be estimated using household measures, using items that 
are familiar to the households (eg, plates, cups, spoons). 
Macronutrient and micronutrient composition, plus 
phytate will be calculated from appropriate food compo-
sition databases. In addition, a selection of commonly 
consumed composite meals will be analysed for mineral, 
macronutrient and phytic acid concentration. During this 
interview, the nutritionist also collected data regarding 
adverse health-related events since the last measurement 
time point. Mothers were also asked to report on the 
frequency and duration of diarrhoeal episodes among 
children in the household. Any major concerns were 
reported to the Health Centre Doctor for follow-up.
Biomarkers of Zn status
Tissue samples were collected from participants attending 
the Health Centre at five time points: baseline, middle 
and end of intervention phase 1, and middle and end of 
phase 2 (figure 1).
Plasma Zn concentration
Whole blood was collected into trace element–free tubes 
(BD Diagnostics, Switzerland) and the plasma separated 
by centrifugation within 40 min. Plasma 300 µL aliquots 
were transferred into Eppendorf tubes and stored at 
−20°C. Plasma samples will be shipped on dry ice to the 
University of Nottingham for analysis by ICP-MS.
DNA fragmentation analysis
DNA fragmentation (measured using the Comet assay) 
has been shown to decrease following dietary Zn supple-
mentation.20 Whole blood was collected by venous blood 
draw. Duplicate samples of 50 µL of whole blood was 
mixed with 50 µL cryopreservation buffer (85% RPMI, 
15% DMSO) in a cryovial and stored in a cryopreserva-
tion container in a fridge for up to 8 hours. Samples were 
transferred from the health centre to Khyber Medical 
University (KMU) on ice and placed in a −80°C freezer 
overnight (up to 12 hours), then transferred to liquid 
nitrogen for storage until samples at all five time points 
have been collected. DNA fragmentation will be quanti-
fied using the method of Singh et al,21 22 and Comet Assay 
IV Lite software (Perceptive Instruments, London, UK) 
for tail moment measurement.
Nail and hair analysis
Whole hairs were collected by combing through the hair 
and collecting individual hairs from the comb, making 
sure that the tag (cells from follicle) is attached to the 
proximal end of the hair. Nail samples were collected at 
baseline. Nail samples will be collected two more times 
at approximately 7 months (average time taken for a 
nail to grow from formation in the nail bed to the tip of 
the finger) from the start of phase 1 and phase 2. The 
Zn concentration of hair and nail samples will be deter-
mined using laser-induced breakdown spectroscopy23 at 
NeurobioTex (Galveston, Texas, USA).
Additional outcomes
Anthropometry
Height and weight of the women were measured at base-
line, and weight was monitored at each sample collection 
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time point. Height was measured using a height board. 
The participant was to stand still with her back towards 
the scale, with the heels, back of the calves, upper back 
and the back of their head touching the board with the 
scale. The head was positioned so that the Frankfurt line 
was straight. The measuring device was lowered gently 
on the hair until it rested gently on the scalp. For the 
measurement of weight, women were asked to relax for 
5 min before being asked to remove added clothes, shoes, 
socks, anything in the pocket, watch or necklace. The 
woman was asked to stand on the marked position on 
the scale until the digital reading or the reading needle 
stabilised. For consistency, weight was measured three 
times and the average calculated. In addition, the height 
and weight of at least one child under 10 years in each 
household will be monitored throughout the interven-
tion period. Mothers were also be asked to keep a diary 
of the frequency and duration of diarrhoeal episodes of 
children in the household throughout the intervention 
period.
Haematological and micronutrient analyses
Haematocrit, haemoglobin, mean corpuscular volume, 
total iron binding capacity and transferrin saturation 
will be estimated using clinical haematology methods. 
Blood samples will be analysed for micronutrient status 
including serum transferrin receptor and ferritin (sand-
wich ELISA), Fe and SE concentrations (ICP-MS), 
vitamin A (retinol-binding protein, RBP) and inflamma-
tory markers (α1-acid glycoprotein and CRP).
Dark adaptation
The potential impact of increasing dietary Zn intake on 
dark adaptation was measured at baseline, week 2, week 
10 and week 18 during the participants’ visits to the 
health centre. Dark adaptation was measured using a 
novel device developed by Labrique and coworkers.24
Stool samples for parasite infection and microbiome analysis
Stools were collected at baseline, week 2, week 10 and 
week 18. Samples were analysed within 24 hours for pres-
ence of parasites. Samples were stored to create a biobank 
for future short-chain fatty acid and microbiome analysis.
dAtA CollECtIon And storAgE
Sample analysis will take place in a number of different 
specialist laboratories in the UK (University of 
Nottingham: plasma Zn, Fe and SE, water, flour), USA 
(NeurobioTex: nail and hair Zn concentration) and Paki-
stan (KMU: Comet assay, haematology, serum transfer-
ring receptor, ferritin, RBP and inflammatory markers). 
Comet assay tail-moment analysis will be undertaken by 
both Pakistan-based (KMU) and UK-based (University 
of Central Lancashire, UCLan) teams, and the results 
compared. Any significant differences will be resolved 
with expert support from the Children’s Hospital Oakland 
Research Institute. Sample analysis will be undertaken 
in duplicate as a minimum requirement. Data entry will 
be undertaken by the expert laboratory and encrypted 
spreadsheets sent to the data hub where a final check for 
anomalies will be made by the database manager. Any 
potential anomalies identified will be checked with the 
expert laboratory. All data will be managed compliant 
with standard BBSRC policies (http://www. bbsrc. ac. 
uk/ web/ FILES/ Policies/ data- sharing- policy. pdf). The 
UCLan will be the data hub for the project; UCLan 
adheres to an Open Data policy and has an open data 
repository. Metadata will be collected in the form of ‘read 
me’ files using basic Dublin Core. This study will generate 
small quantities of personal data from the analysis of 
blood and hair/nail samples. Most of the participants 
were illiterate so verbal informed consent was obtained 
and recorded by the project manager. Participants were 
given an ID number on recruitment, and this will be used 
in all data files. The list of names associated with the ID 
numbers is known only by the project manager and is 
stored in a locked filing cabinet. Data collected in the 
field on laptops are password protected. UCLan systems 
are automatically backed up. Transfer of data between 
laboratories will be in the form of encrypted Excel or 
Word files. Data and metadata will be securely stored in 
a project database and reported on publication. Data will 
be shared with the project steering committee during the 
bi-monthly meetings. This committee is composed of the 
PI and Co-Is. The database manager is undertaking the 
role of data monitoring and all members will have access 
to the final database.
stAtIstICAl AnAlysIs PlAn
The analysis will be performed as intention to treat. 
Descriptive statistics will summarise participants’ charac-
teristics and outcome measurements at each time point, 
using methods appropriate for the type of data. Most 
study outcome measurements will be quantitative data. 
The primary outcome, plasma Zn concentration, was 
collected at five time points (baseline, weeks 4, 8, 12 and 
16). After adjustment for inflammatory markers and as 
described above, the primary outcome will be assessed in 
two type comparisons:
Within-group (A and b) comparisons
Within each group of participants, the study outcome 
will be compared at appropriate time points (base-
line will be compared with week 4 and week 8, week 
4 compared with week 8, week 12 with week 16) to 
assess trend of the change (increase or decrease) in 
Zn concentrations. The pairwise comparisons will be 
done using paired t-test or Wilcoxon signed-rank test 
if normality assumptions for t-test are not satisfied. 
Repeated-measures ANOVA (or its non-parametric 
analogue) will be applied for comparisons at multiple 
time points (eg, to compare study outcome at baseline, 
week 4 and week 8).
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Comparisons between groups A and b
To answer the primary research question of determining 
the effectiveness of consuming flour made from agronom-
ically biofortified wheat for improving Zn status, study 
outcomes will be compared between groups A and B at 
week 8 and week 16, complemented with comparisons at 
interim collection points, week 4 and week 12. The pair-
wise comparisons will be done using independent-sam-
ples t-test or Mann-Whitney U test as appropriate. Linear 
mixed modelling will be used for adjusted analyses to 
account for the baseline, repeated measurements and 
relevant covariates. Similar analysis will be done for all 
secondary outcomes measuring Zn status.
EthICs And dIssEMInAtIon
Ethical approval for the research has been granted from 
the lead University (UCLan) (unique reference number: 
STEMH 697 FR) and the collaborating institution in Paki-
stan, Khyber Medical University. All data collected will be 
anonymised and data protection protocols followed when 
information is shared between participating institutions.
The final study methods (including any modifications) 
will be published in peer-reviewed journals, alongside 
the study outcomes on completion of the data analysis. 
Authorship will be restricted to those who have contrib-
uted to the design of the study, data collection and anal-
ysis, in accordance with journal guidelines. In addition 
to peer-reviewed journals, findings will be disseminated 
to the scientific community via conference presentations 
and abstracts. The findings of the study will be commu-
nicated to the study participants through the village 
elders at an appropriate community forum. More widely, 
the AFPK can access some of the most difficult-to-reach 
communities in KPK and the Federally Administered 
Tribal Area, including through tribal networks, local Jirga 
and religious leaders. We will work with our contacts in 
the agriculture sector to exchange knowledge with key 
actors. For example, the Agricultural Services Depart-
ment of FFC provides soil, water, fertiliser, and plant anal-
ysis and recommendation services (in addition to other 
farmer education/training programmes) to the farming 
community throughout the country. Project partners 
and collaborators are well connected to ensure that new 
evidence can support policy.
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